Protection of Human Subjects: Categories of Research That May Be Reviewed by the Institutional Review Board (IRB) Through an Expedited Review Procedure: Guidance for Institutional Review Boards and Clinical Investigators
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 9, 1998
March 24, 2023
3f36bd8c-c7f3-43b6-8b85-5e6e92984169
Related Documents
Variations in Drug Products that May Be Included in a Single ANDA
Guidance DocumentDecember 1, 1998Center for Drug Evaluation and Research
Institutional Review Board (IRB) Review of Individual Patient Expanded Access Submissions for Investigational Drugs and Biological Products: Guidance for IRBs and Clinical Investigators
Guidance DocumentSeptember 11, 2023Center for Drug Evaluation and Research
S4A Duration of Chronic Toxicity Testing in Animals (Rodent and Nonrodent Toxicity Testing)
Guidance DocumentJune 25, 1999Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.